Insider Stock Trading History of Damelio Frank A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Damelio Frank A since year 2005. The trader's CIK number is 1194004. At the time of this reporting, Damelio Frank A is the Executive Vice President of Pfizer Inc . (stock ticker symbol PFE). See this page for all insider trading activities at Pfizer Inc .

Note that in the past DAMELIO FRANK A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Damelio Frank A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-31 PFE Pfizer Inc Sale 94,409 34.00 3,209,906
2017-02-23 PFE Pfizer Inc Option Ex 218,447 21.03 4,593,940
2016-05-26 PFE Pfizer Inc Option Ex 100,000 24.43 2,443,000
2016-05-26 PFE Pfizer Inc Sale 100,000 34.48 3,448,500
2016-05-10 PFE Pfizer Inc Sale 192,000 33.66 6,462,143
2016-05-10 PFE Pfizer Inc Option Ex 192,000 24.43 4,690,560
2016-05-03 PFE Pfizer Inc Sale 87,079 33.65 2,930,208
2016-02-24 PFE Pfizer Inc Option Ex 210,280 18.90 3,974,291
2015-02-25 PFE Pfizer Inc Option Ex 197,072 17.69 3,486,203
2015-02-11 PFE Pfizer Inc Sale 14,800 34.32 507,995
2015-02-11 PFE Pfizer Inc Sale 80,200 34.20 2,743,000
2014-11-07 PFE Pfizer Inc Sale 0 29.78 0
2014-10-30 PFE Pfizer Inc Option Ex 65,502 17.03 1,115,499
2014-02-26 PFE Pfizer Inc Option Ex 324,932 12.70 4,126,636
2014-01-13 PFE Pfizer Inc Sale 131,810 30.82 4,062,911
2014-01-13 PFE Pfizer Inc Sale 28,190 30.86 869,802
2013-05-20 HUM Humana Inc Option Ex 2,500 23.05 57,625
2013-05-15 PFE Pfizer Inc Sale 100,000 29.32 2,932,500
2013-02-28 PFE Pfizer Inc Option Ex 195,985 22.55 4,419,461
2013-02-06 ZTS Zoetis Inc. Buy 5,000 26.00 130,000
2012-03-30 HUM Humana Inc Option Ex 17,931 55.14 988,679
2008-05-01 HUM Humana Inc Buy 2,075 48.19 99,994
2006-11-21 LU Lucent Technologies Inc Option Ex 664,838 1.42 944,069
2006-11-21 LU Lucent Technologies Inc Sale 209,451 2.61 546,667

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Damelio Frank A (Executive Vice President of Pfizer Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.